Substance Use Tools & Resources    

Reviews the current knowledge and gaps in understanding regarding the effectiveness of MAT for treating OUD, examines the circumstances in which MAT can be effectively delivered, and identifies challenges in implementation.

Provides a basic introduction of the concepts of the disease model of addiction and the role of the reward system. Using neuroscience concepts as a foundation, clinical manifestations of the disease of addiction are then discussed in the form of case-based presentations.

These are slides for a webinar which reviewed the basic concepts and skills of Motivational Interviewing (MI) and employed MI skills and tools, to illustrate the practical applicability of these tools in clinical practice for their addiction and other patient populations.

Provides presentations, documents, forms, and videos about the use of naloxone in opioid overdoses. Resource categories are First Responder Naloxone Training Program, Naloxone Program Forms, Naloxone Training Forms, and Videos.

Provides resources for clinicians interested in initiating buprenorphine treatment in emergency department settings.

Equips healthcare providers, communities, and local governments with material to develop practices and policies to help prevent opioid-related overdoses and deaths. Addresses issues for healthcare providers, first responders, treatment providers, and those recovering from opioid overdose.

Part of the Opioid Overdose Prevention Toolkit. Explains the scope of the opioid use disorder problem, strategies to prevent overdose deaths, and resources for communities.

Highlights the different types of opioids and medication-assisted treatment.

Summarizes the requirements of confidentiality rules set forth under the Code of Federal Regulations (CFR) and suggests steps primary care practices can take to maintain compliance.

Explores the tension between efforts to address the opioid epidemic and the resulting impact on access to pain medications for people facing serious illness; examines the unintended consequences of the responses to the opioid epidemic for patients, families, communities, and clinicians; and considers potential policy opportunities to address them.